Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and Esketamine for Postoperative Recovery in Mastectomy
NCT05283408Completed
- Sponsor
- Anqing Municipal Hospital
- Start
- Apr 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of esketamine in postoperative pain (3 arms), sponsored by Anqing Municipal Hospital. Primary endpoint: Quality of Recovery-15 at 3 days. Started Apr 2022; status: completed.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05283408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05283408.